Drug Type T-lymphocyte cell therapy |
Synonyms Ad5f35LMPd1-2 |
Target |
Mechanism LMP2 inhibitors(Latent membrane protein 2 inhibitors), Latent membrane protein 1 inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hodgkin's Lymphoma | Phase 1 | US | 12 Feb 2012 | |
Leiomyosarcoma | Phase 1 | US | 12 Feb 2012 | |
Non-Hodgkin Lymphoma | Phase 1 | US | 12 Feb 2012 | |
Nasopharyngeal Carcinoma | Phase 1 | US | 30 Jun 2007 |